Viola Baradari

582 total citations
9 papers, 507 citations indexed

About

Viola Baradari is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Viola Baradari has authored 9 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Viola Baradari's work include Cancer Mechanisms and Therapy (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Viola Baradari is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Viola Baradari collaborates with scholars based in Germany and United States. Viola Baradari's co-authors include Hans Scherübl, Alexander Huether, Michael Höpfner, Detlef Schuppan, Detlef Schuppan, Andreas Sutter, Christof Schöfl, M. Ḧopfner and Detlef Schuppan and has published in prestigious journals such as The FASEB Journal, Biochemical Pharmacology and World Journal of Gastroenterology.

In The Last Decade

Viola Baradari

9 papers receiving 500 citations

Peers

Viola Baradari

ONCOL

EPIDE

PFM

SURGE

Margaret Ottaviano Italy

Maria Pia Staccioli Italy

Seok-Hyun Kim South Korea

Toshiro Ogura Japan

Siong‐Seng Liau United Kingdom

Nuria Rodrı́guez-Salas Spain

Dawn Q. Chong Singapore

Zhi-Qiang Meng China

Takahiko Sakaue Japan

Margaret Ottaviano Italy

Viola Baradari

153 ×0.6

193 ×1.0

ONCOL

75 ×0.7

EPIDE

37 ×0.4

PFM

50 ×0.6

SURGE

Citations per year, relative to Viola Baradari Viola Baradari (= 1×) peers Margaret Ottaviano

Countries citing papers authored by Viola Baradari

Since Specialization

Citations

This map shows the geographic impact of Viola Baradari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viola Baradari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viola Baradari more than expected).

Fields of papers citing papers by Viola Baradari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viola Baradari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viola Baradari. The network helps show where Viola Baradari may publish in the future.

Co-authorship network of co-authors of Viola Baradari

This figure shows the co-authorship network connecting the top 25 collaborators of Viola Baradari. A scholar is included among the top collaborators of Viola Baradari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viola Baradari. Viola Baradari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Höpfner, Michael, Viola Baradari, Alexander Huether, & Hans Scherübl. (2008). Growth inhibition of human cholangiocarcinoma by sorafenib‐based mono‐ and combination treatment. The FASEB Journal. 22(S1). 2 indexed citations

Huether, Alexander, Michael Höpfner, Viola Baradari, Detlef Schuppan, & Hans Scherübl. (2007). Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma. Biochemical Pharmacology. 73(9). 1308–1317. 67 indexed citations

Baradari, Viola. (2007). Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells. World Journal of Gastroenterology. 13(33). 4458–4458. 47 indexed citations

Höpfner, Michael, Viola Baradari, Alexander Huether, Christof Schöfl, & Hans Scherübl. (2006). The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours. Endocrine Related Cancer. 13(1). 135–149. 65 indexed citations

Baradari, Viola, Alexander Huether, Michael Höpfner, Detlef Schuppan, & Hans Scherübl. (2006). Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. Endocrine Related Cancer. 13(4). 1237–1250. 60 indexed citations

Höpfner, Michael, Alexander Huether, Andreas Sutter, et al.. (2006). Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells. Biochemical Pharmacology. 71(10). 1435–1448. 97 indexed citations

Huether, Alexander, M. Ḧopfner, Andreas Sutter, et al.. (2006). Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.. PubMed. 12(32). 5160–7. 32 indexed citations

Huether, Alexander, Michael Höpfner, Viola Baradari, Detlef Schuppan, & Hans Scherübl. (2005). EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer. Biochemical Pharmacology. 70(11). 1568–1578. 136 indexed citations

Ḧopfner, M., et al.. (2005). The insulin-like growth factor receptor is a promising target for innovative treatment approaches of hepatocellular cancer. Zeitschrift für Gastroenterologie. 43(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact